^
Association details:
| Biomarker: | YWHAE-NUTM2B translocation |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | pazopanib (Multi-tyrosine kinase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report
Excerpt:
A 40 year old woman was diagnosed with metastatic YWHAE-FAM22 translocated endometrial stromal sarcoma…pazopanib was found to result in a good response in this patient with a YWHAE-FAM22A/B translocated ESS...
DOI:
10.1186/s12885-018-3999-0
